FNY Investment Advisers’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $426K | Buy |
12,895
+2,040
| +19% | +$67.4K | 0.18% | 136 |
|
|
2025
Q1 | $436K | Sell |
10,855
-3,690
| -25% | -$148K | 0.27% | 85 |
|
|
2024
Q4 | $684K | Buy |
14,545
+3,240
| +29% | +$152K | 0.35% | 67 |
|
|
2024
Q3 | $596K | Sell |
11,305
-768
| -6% | -$40.5K | 0.29% | 89 |
|
|
2024
Q2 | $654K | Buy |
12,073
+2,018
| +20% | +$109K | 0.44% | 47 |
|
|
2024
Q1 | $704 | Buy |
+10,055
| New | +$704 | 0.42% | 59 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 487 |
|